PETMED EXPRESS INC(PETS)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

PETMED EXPRESS INC (PETS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PETS at 18.0/100 on a 32-signal composite quality model, placing it at rank #2,817 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (3.6) and institutional flow (5.9), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), PETMED EXPRESS INC reports quarterly revenue of $41.0M, net income of $-6.1M, free cash flow of $-8.3M. Top institutional holders of PETS by reported 13-F value include RENAISSANCE TECHNOLOGIES, VANGUARD CAPITAL MANAGEMENT, BlackRock, based on the most recent SEC filings. PETS trades on the Nasdaq exchange and files with the SEC under CIK 1040130. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PETS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PETMED EXPRESS INC directly from SEC EDGAR.

AI Quality Score

18.0/100

AI Rank

#2,817

Revenue

$41.0M

Net Income

$-6.1M

Free Cash Flow

$-8.3M

PETS key financials by period

PETMED EXPRESS INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202610-K$179.0M$-57.3M-32.8%
FY 202510-K$227.0M$-6.3M-0.7%
FY 202410-K$274.1M$-7.5M-3.0%
FY 202310-K/A$247.6M$5.1M2.4%
FY 202210-K/A$272.3M$18.7M8.9%
FY 202110-K/A$303.6M$23.9M10.1%

Institutions holding PETS

Institutional investors reporting a position in PETMED EXPRESS INC on SEC Form 13F.
InstitutionSharesValueReported
RENAISSANCE TECHNOLOGIES1,131,230$2.2M2026-06-30
VANGUARD CAPITAL MANAGEMENT827,397$1.6M2026-06-30
BlackRock568,255$1.1M2026-06-30
FEDERATED HERMES212,170$407.4K2026-06-30
GEODE CAPITAL MANAGEMENT204,075$391.9K2026-06-30
STEEL PARTNERS L.P.193,664$371.8K2026-06-30
UBS Group AG138,330$265.6K2026-06-30
PRICE T ROWE ASSOCIATES129,933$250.0K2026-06-30
BRIDGEWAY CAPITAL MANAGEMENT121,048$232.4K2026-06-30
Rangeley Capital121,000$232.3K2026-06-30
PETS

PETMED EXPRESS INC

PETS
NasdaqSmall CapHealthcare

13F Pro Quality Score

18.0/100

Rank #2,817 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

3.6/100

Profitability

19.0/100

Balance Sheet

6.7/100

Earnings Quality

20.2/100

Free Cash Flow

14.1/100

Institutional Flow

5.9/100

Revenue Scale

21.5/100

Dilution Risk

64.8/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$41.02M

Net Income

Q2 2026
EDGAR

$-6.14M

EPS (Diluted)

Q2 2026
EDGAR

$-0.28

Free Cash Flow

Q2 2026
EDGAR

$-8.33M

Top Institutional Holders

as of Q2 2026
$8.98M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…